Brimonidine Tartrate Solution/ Drops
Product Images NDC 71921-185

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 71921-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel10ml (10 mL Final)

This is a description of an ophthalmic solution with the active ingredient Brimonidine Tartrate, at a concentration of 0.2%, to be used only in the eyes. The solution is available in a 10mL bottle.*

FDA Label Image

Cartonlabel15ml (15 mL)

NDC 71921-185-15 is a 15mL ophthalmic solution containing 0.2% Brimonidine Tartrate intended for use in the eyes only.*

FDA Label Image

Cartonlabel5ml (5 mL Final)

This is a description of an ophthalmic solution called Brimonidine Tartrate. The product comes in a 5mL bottle and is for use in the eyes only. The manufacturer's contact details are provided; it is essential to keep the solution out of reach of children. It warns against applying the solution to any surface, and the text includes a National Drug Code (NDC) number.*

FDA Label Image

Str (Active)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.